Doha, April 20 (QNA) - Sidra Medicine, a member of Qatar Foundation, has signed a Memorandum of Understanding (MOU) with Germany-based Vitafluence.ai GmbH and its Swiss venture studio, EmpathicAI.Life, to explore potential collaborations in the field of artificial intelligence (AI) and digital health innovation.

The MoU outlines a framework for a three-year collaboration focused on the joint development of initiatives to advance AI-powered healthcare delivery as well as foster innovation within Sidra Medicine's academic medical ecosystem.

The agreement will set the groundwork for pilot programs, knowledge exchange, and co-development of digital solutions designed to support clinical decision-making and personalize patient care, said Sidra Medicine in a press release today.

The MoU was signed by CEO of Sidra Medicine, Dr. Iyabo Tinubu-Karch and Co-Founder of Vitafluence.ai, Dr. Peter O. Owotoki.

CEO of Sidra Medicine, Dr. Iyabo Tinubu-Karch said: "Our joint research, clinical and medical education programs are designed to embrace emerging technologies that can revolutionize diagnostics, treatment and patient care. Working with Vitafluence.ai gives us the opportunity to explore a range of AI-driven applications, including predictive modeling, AI-assisted diagnostics, and tailored treatment pathways, that align with our mission of delivering world-class precision medicine for our patients."

This collaboration represents an incredible opportunity to contribute to Qatar's ambitious vision for medical and digital health advancement, and most importantly, to work together in delivering impactful outcomes for women and children."

The partnership lays the groundwork for introducing cutting-edge digital health solutions into Sidra Medicine's ecosystem, driving forward its commitment to innovation and excellence in care.

Sidra Medicine will be exploring the transformative role of artificial intelligence in advancing global healthcare at its upcoming AI and Medicine 2025 conference from 23-26 April 2025. (QNA)